Development of Primary Monolayer Cell Model and Organotypic Model of Uterine Leiomyoma

Cellular technologies are one of the most promising areas of biomedicine, which is based on the isolation of cells of various types, followed by their cultivation and use, or the use of their metabolic products, for medical purposes. Today, a significant part of biomedical research is carried out in...

Full description

Bibliographic Details
Main Authors: Natalia Shved, Anna Egorova, Natalia Osinovskaya, Anton Kiselev
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Methods and Protocols
Subjects:
Online Access:https://www.mdpi.com/2409-9279/5/1/16
_version_ 1797477571703603200
author Natalia Shved
Anna Egorova
Natalia Osinovskaya
Anton Kiselev
author_facet Natalia Shved
Anna Egorova
Natalia Osinovskaya
Anton Kiselev
author_sort Natalia Shved
collection DOAJ
description Cellular technologies are one of the most promising areas of biomedicine, which is based on the isolation of cells of various types, followed by their cultivation and use, or the use of their metabolic products, for medical purposes. Today, a significant part of biomedical research is carried out in vitro. On the other hand, organotypic culture can be used as a powerful model system and can complement cell culture and in vivo studies in different biomedical applications. Uterine leiomyoma (UL) is a very common benign tumor and often leads to many reproductive complications. Herein we describe a fast and reliable method of isolation and UL primary cells culturing along with the development of a UL organotypic model. We propose the usage of UL primary cells in experimental work at a first passage to prevent loss of driver mutations in <i>MED12</i> and <i>HMGA2</i> genes. New optimized conditions for the growth and maintenance of 2D and 3D models of uterine leiomyoma in vitro are suggested.
first_indexed 2024-03-09T21:19:37Z
format Article
id doaj.art-393bc9af504f4004b164838e855ca9ea
institution Directory Open Access Journal
issn 2409-9279
language English
last_indexed 2024-03-09T21:19:37Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Methods and Protocols
spelling doaj.art-393bc9af504f4004b164838e855ca9ea2023-11-23T21:24:31ZengMDPI AGMethods and Protocols2409-92792022-02-01511610.3390/mps5010016Development of Primary Monolayer Cell Model and Organotypic Model of Uterine LeiomyomaNatalia Shved0Anna Egorova1Natalia Osinovskaya2Anton Kiselev3Department of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, MendeleevskayaLine 3, 199034 Saint-Petersburg, RussiaDepartment of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, MendeleevskayaLine 3, 199034 Saint-Petersburg, RussiaDepartment of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, MendeleevskayaLine 3, 199034 Saint-Petersburg, RussiaDepartment of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, MendeleevskayaLine 3, 199034 Saint-Petersburg, RussiaCellular technologies are one of the most promising areas of biomedicine, which is based on the isolation of cells of various types, followed by their cultivation and use, or the use of their metabolic products, for medical purposes. Today, a significant part of biomedical research is carried out in vitro. On the other hand, organotypic culture can be used as a powerful model system and can complement cell culture and in vivo studies in different biomedical applications. Uterine leiomyoma (UL) is a very common benign tumor and often leads to many reproductive complications. Herein we describe a fast and reliable method of isolation and UL primary cells culturing along with the development of a UL organotypic model. We propose the usage of UL primary cells in experimental work at a first passage to prevent loss of driver mutations in <i>MED12</i> and <i>HMGA2</i> genes. New optimized conditions for the growth and maintenance of 2D and 3D models of uterine leiomyoma in vitro are suggested.https://www.mdpi.com/2409-9279/5/1/16uterine leiomyomacell modelorganotypic model<i>MED12</i><i>HMGA2</i>
spellingShingle Natalia Shved
Anna Egorova
Natalia Osinovskaya
Anton Kiselev
Development of Primary Monolayer Cell Model and Organotypic Model of Uterine Leiomyoma
Methods and Protocols
uterine leiomyoma
cell model
organotypic model
<i>MED12</i>
<i>HMGA2</i>
title Development of Primary Monolayer Cell Model and Organotypic Model of Uterine Leiomyoma
title_full Development of Primary Monolayer Cell Model and Organotypic Model of Uterine Leiomyoma
title_fullStr Development of Primary Monolayer Cell Model and Organotypic Model of Uterine Leiomyoma
title_full_unstemmed Development of Primary Monolayer Cell Model and Organotypic Model of Uterine Leiomyoma
title_short Development of Primary Monolayer Cell Model and Organotypic Model of Uterine Leiomyoma
title_sort development of primary monolayer cell model and organotypic model of uterine leiomyoma
topic uterine leiomyoma
cell model
organotypic model
<i>MED12</i>
<i>HMGA2</i>
url https://www.mdpi.com/2409-9279/5/1/16
work_keys_str_mv AT nataliashved developmentofprimarymonolayercellmodelandorganotypicmodelofuterineleiomyoma
AT annaegorova developmentofprimarymonolayercellmodelandorganotypicmodelofuterineleiomyoma
AT nataliaosinovskaya developmentofprimarymonolayercellmodelandorganotypicmodelofuterineleiomyoma
AT antonkiselev developmentofprimarymonolayercellmodelandorganotypicmodelofuterineleiomyoma